| Liu DV, Maier LM, Hafler DA, et al.
Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | van de Ven R, Lindenberg JJ, Oosterhoff D, et al.
Selective Transduction of Mature DC in Human Skin and Lymph Nodes by CD80/CD86-targeted Fiber-modified Adenovirus-5/3. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Na IK, Letsch A, Guerreiro M, et al.
Human Bone Marrow as a Source to Generate CMV-specific CD4+ T Cells With Multifunctional Capacity. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | | Dillman RO, Duma CM, Ellis RA, et al.
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | Find Related Articles | | Carbone A, Vizio B, Novarino A, et al.
IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | Find Related Articles | | Brestrich G, Zwinger S, Roemhild A, et al.
Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy. [JOURNAL ARTICLE]
J Immunother 2009 Oct 6.
Abstract | Full Citation | Find Related Articles | | Dang N, Hu J, Liu X, et al.
CD167 Acts as a Novel Costimulatory Receptor in T-Cell Activation. [JOURNAL ARTICLE]
J Immunother 2009 Sep 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lindqvist C, Sandin LC, Fransson M, et al.
Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition. [JOURNAL ARTICLE]
J Immunother 2009 Sep 11.
Abstract | Full Citation | | Sasaki K, Pardee AD, Qu Y, et al.
IL-4 Suppresses Very Late Antigen-4 Expression Which is Required for Therapeutic Th1 T-cell Trafficking Into Tumors. [JOURNAL ARTICLE]
J Immunother 2009 Sep 11.
Abstract | Full Citation | | Tsuno T, Mejido J, Zhao T, et al.
IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-alpha. [JOURNAL ARTICLE]
J Immunother 2009 Sep 11.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
